Therapeutic Use of Oral Sodium Phosphate (Z-521) in Primary Hypophosphatemic Rickets

Status:
Completed

Trial end date:
2013-07-01

Target enrollment:

Participant gender:

The purpose of this study is to investigate the efficacy and safety of oral phosphate (Z-521) in subjects with primary hypophosphatemic rickets.

Phase 3

Zeria Pharmaceutical